Synlogic announces pricing of public offering of common stock

Cambridge, mass., sept. 22, 2021 /prnewswire/ -- synlogic (nasdaq: sybx) a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the pricing of its underwritten public offering of 15,000,000 shares of its common stock at a public offering price of $3.00 per share.

SYBX Ratings Summary

SYBX Quant Ranking